Human antibodies derived from immunized xenomice
US6713610B1 · kind B1 · utility
124Cited by
7References
14Claims
0Family size
Inventors
Key dates
| Filing date | Jul 11, 2000 |
| Grant date | Mar 30, 2004 |
| Priority date | — |
| Expiry date | Sep 1, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/203
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Fully human antibodies against a specific antigen can be prepared by administering the antigen to a transgenic animal which has been modified to produce such antibodies in response to antigenic challenge, but whose endogenous loci have been disabled. Various subsequent manipulations can be performed to obtain either antibodies per se or analogs thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.